Amphastar Pharma | AMPH | Risky Short?
Updated
Amphastar Pharmaceuticals ( 
AMPH ) is currently at historical resistance after reaching a new high today at $34.42. It's now above the average analyst target ($28.50 as of 3/7/2022) and insiders have sold $2.2 million in the past 2 months. Earnings on March 10th. The float is near 37 million with a 5.5% short interest. It is at "risk" for a squeeze/breakout, but given how extended the play is, there could be a selloff post-earnings. Gap to fill below between $26.20-$26.49. Target 1 is the gap fill / 50 EMA (yellow line).
AMPH ) is currently at historical resistance after reaching a new high today at $34.42. It's now above the average analyst target ($28.50 as of 3/7/2022) and insiders have sold $2.2 million in the past 2 months. Earnings on March 10th. The float is near 37 million with a 5.5% short interest. It is at "risk" for a squeeze/breakout, but given how extended the play is, there could be a selloff post-earnings. Gap to fill below between $26.20-$26.49. Target 1 is the gap fill / 50 EMA (yellow line).Trade closed: stop reached
Earnings beat. Breakout. Failed idea in the near-term. Congrats to the bulls!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.